Discontinuation of Oxytocin in the Second Stage of Labor and its Association with Postpartum Hemorrhage.

Autor:	MacGregor, Caitlin, Plunkett, Beth, Adams, Marci, Silver, Richard
Předmět:	OXYTOCIN CESAREAN section MATERNAL health services DELIVERY (Obstetrics) TERMINATION of treatment MULTIPLE regression analysis POSTPARTUM hemorrhage PREGNANT women EVALUATION of medical care RETROSPECTIVE studies DESCRIPTIVE statistics SECOND stage of labor (Obstetrics) LONGITUDINAL method ODDS ratio MEDICAL records ACQUISITION of data GESTATIONAL age ELECTRONIC health records STATISTICS COMPARATIVE studies CONFIDENCE intervals EVALUATION PREGNANCY
Zdroj:	American Journal of Perinatology; Jun2024, Vol. 41 Issue 8, p1050-1054, 5p
Abstrakt:	Objective The objective of the study was to evaluate whether patients with oxytocin discontinued during the second stage of labor (≥30 minutes prior to delivery) had a lower rate of postpartum hemorrhage (PPH) compared with those with oxytocin continued until delivery or discontinued <30 minutes prior to delivery. Study Design Retrospective cohort study was performed from August 1, 2014 to July 31, 2019. Singleton pregnancies of 24 to 42 weeks gestation were included if they reached the second stage of labor and received oxytocin during labor. Patients on anticoagulants were excluded. Patients with oxytocin discontinued ≥30 minutes prior to delivery represented STOPPED and those with oxytocin continued until delivery or discontinued <30 minutes prior to delivery represented CONTINUED. Patient data were abstracted from the electronic medical record. The primary outcome was PPH (≥1,000 mL blood loss). Univariable analyses were performed to compare groups. Multi-variable logistic regression was performed to adjust for prespecified confounders. Planned sub-group analyses by the route of delivery were performed. Results Of 10,421 total patients, 1,288 had oxytocin STOPPED and 9,133 had oxytocin CONTINUED. There were no significant differences in age, race, or ethnicity, body mass index, public insurance, gestational diabetes, or pregnancy-induced hypertension between STOPPED and CONTINUED. The PPH rate was 15.2 and 5.7% in STOPPED and CONTINUED, respectively (p < 0.001). After adjusting for confounders, STOPPED remained at higher odds for PPH (adjusted odds ratio 2.859, 95% confidence interval 2.394, 3.414, p < 0.001). Among cesarean deliveries only, there was no significant difference in the rate of PPH between STOPPED and CONTINUED (38.0 vs. 36.4%, respectively, p = 0.730). However, among vaginal deliveries, the rate of PPH was actually lower in STOPPED than CONTINUED (3.4 vs. 5.2%, respectively, p = 0.024). Conclusion The rate of PPH was higher in patients with oxytocin STOPPED compared with CONTINUED. However, among vaginal deliveries, there was a significantly lower rate of PPH in STOPPED. These disparate findings may be explained by the variable impact of second-stage oxytocin on PPH as a function of delivery type. Key Points It is unclear if oxytocin use in the second stage of labor may independently increase the risk of hemorrhage. Patients with oxytocin discontinued during the second stage of labor had a higher rate of PPH. PPH was significantly lower among vaginal deliveries in patients with oxytocin discontinued. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu